Triantafyllos (Lakis) Liloglou received his BSc (hons) in Biology from the Aristotelian University of Thessaloniki, Greece. Following his national service in the Greek Army as 2nd Lieutenant, he undertook his PhD in Molecular Oncology at the University of Crete Medical School. After his post-doctoral training at the University of Liverpool he became a junior group leader while joining the Liverpool Lung Project in 1998. In 2010 he was appointed as a Lecturer in Molecular Oncology at the University of Liverpool and promoted to Senior Lecturer in 2013. In August 2021, he joined Edge Hill University as a Senior Lecturer in Postgraduate Medical Education. He is currently The Programme Leader for the Master of Surgery (MCh) and continues his research in respiratory cancer being an active member of The Liverpool Lung Project and Liverpool Head and Neck Cancer.
Dr Liloglou’s research interests focus in genetic and epigenetic instability in cancers of the respiratory tract. Particular emphasis is given to the discovery and validation of biomarkers for clinical management (early detection and therapeutic stratification).
A number of projects are currently on going, on non-coding RNAs, DNA methylation and HDAC inhibitors.